As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast ...

Author, speaker and health content creator Dr Liz O’Riordan shares her journey from consultant breast surgeon to cancer ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Abu Dhabi: BioTwin, a cutting-edge Canadian digital health startup that is part of Hub71, Abu Dhabi’s global tech ecosystem, ...

Should I get breast implants? Should they be saline or silicone? Which style? How much monitoring is needed after surgery?

The European Medicines Agency has recommended three new medicines to treat breast and cervical cancer and ...

The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...

One of the most important launches for Novartis in recent years is off with a bang. | One of the most important launches for ...

For the first time, she received medical treatment from consultant of colorectal surgeon of Dhaka in a health camp at Masimpur village Sirajganj Sadar upazila this morning ...

The Swiss pharmaceutical company said the FDA backed a label expansion for the Pathway HER2 (4B5) test to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who could be ...

This initiative aims to enhance access to cancer treatment and support for patients across the country, addressing a critical gap in healthcare services.

Union Budget 2025: 36 life-saving drugs and medicines would be added to the list of medicines fully exempted from basic customs duty.